Vivanza Biosciences

BSE: 530057 29 Jun 2025

Healthcare

₹ 2.21

Vivanza Biosciences Limited specializes in Pharmaceuticals within the Healthcare sector.

Vivanza Biosciences

BSE: 530057 29 Jun 2025

Healthcare

₹ 2.21

Vivanza Biosciences Limited specializes in Pharmaceuticals within the Healthcare sector.

Book Value

1.0

Dividend Yield

0.0%

Debt to Equity

1.52

Stock P/E

Market Cap

9.48 Cr

Vivanza Biosciences - Share Price & Details

Market Cap

₹9.48

High /Low

6.09 / 1.9

Stock P/E

Book Value

₹1.0

Dividend Yield

0.0

ROCE

-3.76

ROE

₹-16.0

Face Value

1.0

PEG Ratio

EVEBITDA

₹-47.1

Debt

6.10

CMP / FCF

-49.0

Debt to equity

₹1.52

NP Ann

-0.70

High price all time

21.0

Piotroski score

₹1.0

Graham Number

No. Eq. Shares

4.0

Net CF

₹-0.04

Net profit

-0.70

Price to book value

2.36

Interest Coverage

₹-0.97

Low price all time

0.44

Industry PE

33.8

Reserves

₹0.02

Free Cash Flow

₹-2.48

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
LOOKS HEALTH SERVICES LIMITED	NA	NA	NA	NA	5.11	256.0
Triochem Products Ltd.,	NA	NA	NA	NA	0
Vivanza Biosciences Limited	NA	NA	NA	NA	9.48
DR LALCHANDANI LABS LIMITED	NA	NA	NA	NA	8.56	20.4
Satiate Agri Limited	NA	NA	NA	NA	8.55

Peer Comparison Chart

About Vivanza Biosciences

Vivanza Biosciences Limited, with Security Code 530057, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Latest News

Prudent Corporate Advisory Services consolidated net profit rises 16.09% in the March 2025 quarter

(14 May 2025)

Sales rise 18.08% to Rs 283.03 crore. Net profit of Prudent Corporate Advisory Services rose 16.09% to Rs 51.74 crore in the quarter ended...

Share Market Today | Latest Stock Market News, Sensex Today and Nifty Live Updates

(13 May 2025)

The Board of Directors of the Company at its meeting held today i.e. Monday 12th May 2025 at Registered Office of the Company has inter alia considered and...

Vivanza Biosciences Reports Significant Operational Challenges in March 2025 Financial Results

(13 May 2025)

Vivanza Biosciences has reported its financial results for the quarter ending March 2025, highlighting operational challenges. The company recorded its...

Vivanza Bio Standalone March 2025 Net Sales at Rs 0.17 crore, down 92.62% Y-o-Y

(13 May 2025)

Net Sales at Rs 0.17 crore in March 2025 down 92.62% from Rs. 2.30 crore in March 2024. Story continues below Advertisement.

Vivanza Bio Consolidated March 2025 Net Sales at Rs 0.48 crore, down 89.08% Y-o-Y

(13 May 2025)

Net Sales at Rs 0.48 crore in March 2025 down 89.08% from Rs. 4.42 crore in March 2024. Story continues below Advertisement.

Arco Leasing reports consolidated net loss of Rs 0.04 crore in the March 2025 quarter

(13 May 2025)

Sales decline 50.00% to Rs 0.02 crore.

Quarterly Table

Standalone Consolidated

Metrics	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	1.0	4.8	6.0	4.9	3.9	3.4	2.3	0.4	1.6	0.8
Expenses	1.0	4.3	6.0	4.5	3.6	3.1	2.4	0.1	1.5	0.6
Operating Profit	0.0	0.5	0.0	0.4	0.2	0.3	-0.1	0.3	0.1	0.1
OPM %	1.05%	10.81%	0.75%	8.7%	6.3%	7.96%	-5.87%	74.53%	6.25%	15.62%
Other Income	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
Interest	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Depreciation	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Profit before tax	0.1	0.4	0.1	0.3	0.2	0.2	-0.3	0.2	0.0	0.0
Tax %	0%	0%	-187.3%	0%	0%	0%	41.9%	0%	0%	0%
Net Profit	0.1	0.4	-0.1	0.3	0.2	0.2	-0.4	0.2	0.0	0.0
EPS in Rs	0.37	1.04	-0.14	0.01	0.05	0.01	-0.09	0.06		0.01

Metrics	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	1.4	5.9	8.2	9.2	7.6	6.6	4.4	2.4	3.0	1.5
Expenses	1.4	5.3	8.2	8.6	7.3	6.3	4.6	2.1	2.9	1.4
Operating Profit	0.0	0.6	0.0	0.6	0.3	0.3	-0.1	0.4	0.1	0.1
OPM %	-1.4%	9.56%	-0.04%	6.42%	4.19%	4.45%	-3.03%	14.68%	3.67%	8.33%
Other Income	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
Interest	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Depreciation	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Profit before tax	0.2	0.5	0.0	0.5	0.3	0.2	-0.3	0.3	0.0	0.0
Tax %	0%	0%	-786.7%	0%	0%	0%	55.6%	0%	0%	0%
Net Profit	0.2	0.5	-0.1	0.5	0.3	0.2	-0.4	0.3	0.0	0.0
EPS in Rs	0.42	1.15	-0.26	0.12	0.07	0.01	-0.1	0.07		0.01

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	0%
5 Years:	-21%
3 Years:	-31%
TTM:	-80%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	-319%

Stock Price CAGR
10 Years:	15%
5 Years:	0%
3 Years:	-47%
1 Year:	-61%

Compounded Sales Growth
10 Years:	0%
5 Years:	-5%
3 Years:	-11%
TTM:	-73%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	-222%

Stock Price CAGR
10 Years:	15%
5 Years:	0%
3 Years:	-47%
1 Year:	-61%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

Vivanza Biosciences

Vivanza Biosciences

Vivanza Biosciences - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About Vivanza Biosciences

Latest News

Prudent Corporate Advisory Services consolidated net profit rises 16.09% in the March 2025 quarter

Share Market Today | Latest Stock Market News, Sensex Today and Nifty Live Updates

Vivanza Biosciences Reports Significant Operational Challenges in March 2025 Financial Results

Vivanza Bio Standalone March 2025 Net Sales at Rs 0.17 crore, down 92.62% Y-o-Y

Vivanza Bio Consolidated March 2025 Net Sales at Rs 0.48 crore, down 89.08% Y-o-Y

Arco Leasing reports consolidated net loss of Rs 0.04 crore in the March 2025 quarter

Board Meeting Outcome for Outcome Of Board Meeting Held Today 12Th May 2025

VIVANZA BIOSCIENCES ANNOUNCES BOARD MEETING DATE

Q4 Results Today: Tata Steel, Raymond, PVR Inox, Ather Energy Among 80 Firms To Declare Earnings On May 12

Q4 Results 2025 Today, May 12: Tata Steel, SRF, UPL, PVR Inox among 80 NSE, BSE companies to declare quarterly earnings

Q4 results: Tata Steel, Raymond, SRF, Ather Energy, PVR Inox, UPL, others to declare earnings on May 12; check list

Vivanza Biosciences to hold board meeting

Vivanza Biosciences Hits All-Time Low Amidst Ongoing Financial Challenges and Declining Stakeholder Confidence

Vivanza Biosciences Hits 52-Week Low Amid Ongoing Financial Challenges and Stakeholder Concerns

Vivanza Biosciences Faces Challenges Amid Significant Stock Decline and Weak Fundamentals

Vivanza Biosciences Faces Major Financial Challenges Amidst Declining Stakeholder Confidence

Vivanza Biosciences Hits All-Time Low Amid Ongoing Financial Struggles and Volatility

Vivanza Biosciences reports consolidated net loss of Rs 1.00 crore in the March 2025 quarter

Godrej Agrovet consolidated net profit rises 21.40% in the December 2024 quarter

Sensex falls! But these stocks gained over 10% on BSE

Sensex falls! These stocks are down 5% or more on BSE

Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today

Vivanza Biosciences Hits 52-Week Low at Rs. 3.21 Amid Ongoing Decline

Ten stocks close to their 52-week low

Bulk Deals | Buyer | Seller | BSE | NSE | Stock as on Nov 16, 2024

Bulk Deals | Buyer | Seller | BSE | NSE | Stock as on Nov 19, 2024

Bulk Deals | Buyer | Seller | BSE | NSE | Stock as on Nov 11, 2024

Bulk Deals | Buyer | Seller | BSE | NSE | Stock as on Oct 29, 2024

Vivanza Bio Consolidated September 2024 Net Sales at Rs 3.00 crore, down 60.63% Y-o-Y

Vivanza Bio Standalone September 2024 Net Sales at Rs 1.58 crore, down 59.11% Y-o-Y

Vivanza Biosciences Hits 52-Week Low, Underperforming Sector by 3.27%

Vivanza Biosciences' Stock Hits 52-Week Low, Underperforms Market by -66.25%

Vivanza Biosciences consolidated net profit declines 92.31% in the September 2024 quarter

5Paisa Capital consolidated net profit rises 15.02% in the September 2024 quarter

Q2 results today: Axis Bank, Infosys, Wipro, Nestle India, others to announce earnings on October 17; check list

Q2 Results Today: Infosys, Wipro, Axis Bank, Havells And Polycab Earnings To Be In Focus On Oct. 17

Q2-FY25 Results: Infosys, Axis Bank, Nestle India, Central Bank among 36 companies to post July-September p...

Q2FY25 Results: Infosys, Axis Bank, Nestle India, Central Bank among 36 companies to post July-September pe...

Q2FY25 Results: Infosys, Axis Bank, Nestle India, Central Bank among 36 companies to post July-September performance today

Q2 Results: HCL Tech, Bajaj Auto, RIL, Axis Bank among 144 companies to declare July-Sept quarter results this week | Company Business News

Q2 Results: HCL Tech, Bajaj Auto, RIL, Axis Bank among 144 companies to declare July-Sept quarter results this week

Vivanza Biosciences to declare Quarterly Result

Vivanza Biosciences Hits 52-Week Low and Receives Strong Sell Rating

Vivanza Bio Consolidated June 2024 Net Sales at Rs 2.44 crore, down 73.57% Y-o-Y

Q1 results today: LIC, Oil India, Bharat Forge, SAIL, Cochin Shipyard, Bayer Cropscience, ABB & more to report earnings | Company Business News

Sensex falls! These stocks fell 5% or more in Friday's session

Vivanza Bio Standalone June 2024 Net Sales at Rs 0.43 crore, down 91.23% Y-o-Y

Trending Stocks Today

Vivanza Biosciences consolidated net profit declines 44.90% in the June 2024 quarter

Q1 Results, Aug 8: RVNL, LIC, MRF, IRCON International, Eicher Motors To Declare Earnings Today

Vivanza Biosciences Hits 52-Week Low, Receives 'Strong Sell' Rating from MarketsMOJO

VST Industries announces 10:1 bonus issue, sets August 30 as the record date

MTNL shares double in seven trading sessions after govt release funds for bond payment

Garden Reach Shipbuilders shares snap two-day losing streak, rise 5% on signing two MoUs

President of India-backed railway logistics company signs an MoU with Shipping Corporation of India Ltd – know more here!

Vivanza Biosciences Q4 Results Live : loss rise by 309.27% YOY | Company Business News

Vivanza Biosciences reports consolidated net loss of Rs 0.41 crore in the March 2024 quarter

Q4 results today: Indian Oil, REC, Adani Energy and Havells among 56 companies to report Q4 earnings on April 30 | Stock Market News

Q4 2024 Quarterly Results Today 30th April: Dividend, earnings announcement schedule

Q4 results today: Indian Oil, REC, Adani Energy and Havells among 56 companies to report Q4 earnings on April 30

Q4 results: Tata Chemicals, Adani Enterprises, IOC, Titan among 211 companies to declare earnings this week | Company Business News

Penny Stocks Under Rs 10 with High Trading and Delivery Volumes

Vivanza Biosciences Share Price

Vivanza Biosciences Ltd reports Net Profit Jump of 37 per cent in 9MFY24; Total Income more than doubles to Rs. 23.50 crore

Vivanza Biosciences Reports Net Profit Jump Of 37% In 9MFY24

Share Market Highlights 04 January 2024: Sensex climbs 491 pts; Nifty closes above 21,650; realty index jumps over 6%

Q2 Results today: PNB, Asian Paints, ACC, others to announce earnings | Company Business News

Gufic Biosciences Limited granted patent for an invention

Shares below Rs 100: Only buyers were seen in these stocks on July 10

These shares will trade ex-split, ex-bonus. Do you own any. | Stock Market News

Multibagger Stock: कमजोर बाजार में भी रॉकेट हुआ ये स्टॉक; 6 दिन से लग रहा अपर सर्किट, क्या आपके पोर्टफोलियो में है शेयर?